Scholars@Duke

Adaptimmune MAGE A-4

Clinical Trial Grant
Duke Scholars
Jeffrey Melson Clarke
Principal Investigator Jeffrey Melson Clarke Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Adaptimmune Limited

Start Date

December 17, 2018

End Date

November 30, 2020
 

Administered By

Duke Cancer Institute

Awarded By

Adaptimmune Limited

Start Date

December 17, 2018

End Date

November 30, 2020